L. V. Wilton

Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

Richard M. Martin, L. V. Wilton, Ronald D. Mann · BMJ · 1998 · 153 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

L. V. Wilton, G. L. Pearce, Richard M. Martin et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1998 · 148 citations

Public Health, Maternal Health, Obstetrics +15

Safety of Long‐Term Lamotrigine in Epilepsy

F. J. Mackay, L. V. Wilton, G. L. Peace et al. · Epilepsia · 1997 · 147 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +11

A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies

L. V. Wilton, G. L. Pearce, Ronald D. Mann · British Journal of Clinical Pharmacology · 1996 · 113 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

W.H.W. Inman, Nigel S. B. Rawson, L. V. Wilton et al. · BMJ · 1988 · 113 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12